Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression

Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression

Show other versions (2)

Detalhes bibliográficos
Main Authors:	Schödel, J, Bardella, C, Sciesielski, L, Brown, J, Pugh, C, Buckle, V, Tomlinson, I, Ratcliffe, P, Mole, DR
Formato:	Journal article
Publicado em:	2012

Registos relacionados

Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
Por: Schödel, J, et al.
Publicado em: (2012)

Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression.
Por: Schödel, J, et al.
Publicado em: (2012)

Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer
Por: Grampp, S, et al.
Publicado em: (2016)

High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq.
Por: Schödel, J, et al.
Publicado em: (2011)

Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer
Por: Steffen Grampp, et al.
Publicado em: (2016-10-01)

Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway.
Por: Grampp, S, et al.
Publicado em: (2017)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
Por: Chan, M, et al.
Publicado em: (2016)

Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway.
Por: Steffen Grampp, et al.
Publicado em: (2017-07-01)

Deletion 22q13.3 syndrome
Por: Phelan Mary C
Publicado em: (2008-05-01)

Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
Por: Mole, D, et al.
Publicado em: (2001)

11q13 is a susceptibility locus for hormone receptor positive breast cancer
Por: Lambrechts, D, et al.
Publicado em: (2012)

11q13 is a susceptibility locus for hormone receptor positive breast cancer.
Por: Lambrechts, D, et al.
Publicado em: (2012)

Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2.
Por: Choudhry, H, et al.
Publicado em: (2014)

Extensive regulation of the non-coding transcriptome by hypoxia: role of HIF in releasing paused RNApol2
Por: Choudhry, H, et al.
Publicado em: (2013)

Pan-genomic binding of hypoxia-inducible transcription factors.
Por: Schödel, J, et al.
Publicado em: (2013)

Focus on 16p13.3 Locus in Colon Cancer.
Por: Evi Mampaey, et al.
Publicado em: (2015-01-01)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
Por: Tuckerman, JR, et al.
Publicado em: (2004)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
Por: Mole, D, et al.
Publicado em: (2003)

The psychiatric phenotype of 15q11.2-q13.3 duplications
Por: M. Budisteanu, et al.
Publicado em: (2021-04-01)

Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis.
Por: Lakhal, S, et al.
Publicado em: (2011)

Regulation of HIF: prolyl hydroxylases.
Por: Stolze, I, et al.
Publicado em: (2006)

Regulation of angiogenesis by hypoxia: role of the HIF system.
Por: Pugh, C, et al.
Publicado em: (2003)

Regulation of the HIF pathway: enzymatic hydroxylation of a conserved prolyl residue in hypoxia-inducible factor alpha subunits governs capture by the pVHL E3 ubiquitin ligase complex.
Por: Mole, D, et al.
Publicado em: (2002)

Activation of the HIF pathway in cancer.
Por: Maxwell, P, et al.
Publicado em: (2001)

Thyroid cancer susceptibility polymorphisms: Confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24
Por: Jones, A, et al.
Publicado em: (2012)

Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk.
Por: Jaeger, E, et al.
Publicado em: (2008)

Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24.
Por: Jones, A, et al.
Publicado em: (2012)

A 15q13.3 microdeletion segregating with autism.
Por: Pagnamenta, A, et al.
Publicado em: (2009)

Targeting tumors through the HIF system.
Por: Ratcliffe, P, et al.
Publicado em: (2000)

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.
Por: French, J, et al.
Publicado em: (2013)

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Por: French, J, et al.
Publicado em: (2013)

Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts.
Por: Mole, D, et al.
Publicado em: (2009)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
Por: Schlemminger, I, et al.
Publicado em: (2003)

Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours.
Por: Wang, Z, et al.
Publicado em: (1999)

Difficulty in genetic counseling of an asymptomatic carrier woman with a de novo 15q13.2q13.3 microdeletion encompassing CHRNA7 and OTUD7A and recurrent 15q13.2q13.3 microdeletion in the fetus
Por: Chih-Ping Chen
Publicado em: (2025-01-01)

Osteoarthritis-susceptibility locus on chromosome 11q, detected by linkage.
Por: Chapman, K, et al.
Publicado em: (1999)

Hereditary motor and autonomic neuronopathy 1 maps to chromosome 20q13.2-13.3
Por: W. Marques Jr., et al.
Publicado em: (2004-11-01)

The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.
Por: Pugh, C, et al.
Publicado em: (2003)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
Por: Tian, Y, et al.
Publicado em: (2006)

The pVHL-hIF-1 system. A key mediator of oxygen homeostasis.
Por: Maxwell, P, et al.
Publicado em: (2001)